Oxana Kukhaneva

Venture Capital Investor

📍 Switzerland🔄 Updated September 2026💼 5 investments📅 6 years investing🗓 Last invested Dec 2024
VC🌍 Switzerland
5
Total investments
2
Early stage
2
Mid stage
0
Late stage
6y
Years active

Portfolio

5 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Dec 2024
RevivBio leverages Generative AI and Ultrahigh Throughput experimentation to design better proteins
Board Member
Sep 2023
Allozymes is a fast-growing biotechnology company that applies its proprietary ultra-high-throughput platform technology to rapidly develop novel enzymes and unlock the bioeconomy across sectors. Leveraging this ultra-high screening power, Allozymes aims to build the largest enzyme data library in the world to address the current and future needs of building robust biosolutions.
Board Observer
Sep 2022
Standing Ovation is a French protein company specializing in precision fermentation. The company has developed its first patented ingredient, Advanced Casein®, which is produced with 10 times less CO2, and significantly less water consumption and land use than regular casein, while offering nutritional, functional and taste qualities on par with the animal-sourced protein. Standing Ovation will launch its flagship protein in the United States in 2025 and aims to be a global leader in the food and environmental transition. As a winner of the French Tech 2030 program, Standing Ovation has received government backing and support from leading shareholders for its industrialization, and signed a strategic partnership with the Bel Group in 2022.
early stageFood Production
Board Member
Jan 2022
At La Vie™ we love meat, but much less its impact on life. Were on a mission to make people evolve from animal-based meat to plant-based, with a big happy smile on their face and some fat on their fingertips. Our patented vegetal fat recipe allows us to propose juicy plant-based meat. Experiences like no other. Jump on our shoulders, and follow our movement. From plants with Love, La Vie™.
Early inception investor
May 2020
one.bio is a fast-paced, emerging biotechnology spinout from UC Davis creating ingredients for food and biopharmaceutical applications. We use proprietary technology to create novel oligosaccharides from natural products, with a focus on producing ingredients that beneficially modulate the microbiome and immune function.
Experience · 8 entries
All (8)
Investments (5)
Board (4)
2024
Board Member
Dec 2024
RevivBio leverages Generative AI and Ultrahigh Throughput experimentation to design better proteins
2023
Board Member
Sep 2023
Allozymes is a fast-growing biotechnology company that applies its proprietary ultra-high-throughput platform technology to rapidly develop novel enzymes and unlock the bioeconomy across sectors. Leveraging this ultra-high screening power, Allozymes aims to build the largest enzyme data library in the world to address the current and future needs of building robust biosolutions.
2022
Board Observer
Sep 2022
Standing Ovation is a French protein company specializing in precision fermentation. The company has developed its first patented ingredient, Advanced Casein®, which is produced with 10 times less CO2, and significantly less water consumption and land use than regular casein, while offering nutritional, functional and taste qualities on par with the animal-sourced protein. Standing Ovation will launch its flagship protein in the United States in 2025 and aims to be a global leader in the food and environmental transition. As a winner of the French Tech 2030 program, Standing Ovation has received government backing and support from leading shareholders for its industrialization, and signed a strategic partnership with the Bel Group in 2022.
early stageFood Production
Board Member
Jan 2022
At La Vie™ we love meat, but much less its impact on life. Were on a mission to make people evolve from animal-based meat to plant-based, with a big happy smile on their face and some fat on their fingertips. Our patented vegetal fat recipe allows us to propose juicy plant-based meat. Experiences like no other. Jump on our shoulders, and follow our movement. From plants with Love, La Vie™.
2020
Early inception investor
May 2020
one.bio is a fast-paced, emerging biotechnology spinout from UC Davis creating ingredients for food and biopharmaceutical applications. We use proprietary technology to create novel oligosaccharides from natural products, with a focus on producing ingredients that beneficially modulate the microbiome and immune function.
Show all 8 entries ↓
Investment activity
2020–2024 · 5 investments
20201202222023120241
Recent (last 2 years)Earlier